Clinical trial
Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes
NCT03534193 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes
- Lead sponsor
- Hackensack Meridian Health
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 17, 2017
- Completion date
- April 8, 2025
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes mellitus